Steven J. Mento Ph.D.
Net Worth

Last updated:

What is Steven J. Mento Ph.D. net worth?

The estimated net worth of Dr. Steven J. Mento Ph.D. is at least $15,720,000 as of 22 May 2020. He has received compensation worth at least $15,720,000 in Histogen Inc..

What is the salary of Steven J. Mento Ph.D.?

Dr. Steven J. Mento Ph.D. salary is $1,310,000 per year as Executive Chairman, Interim Pres & Chief Executive Officer in Histogen Inc..

How old is Steven J. Mento Ph.D.?

Dr. Steven J. Mento Ph.D. is 73 years old, born in 1952.

What stocks does Steven J. Mento Ph.D. currently own?

As insider, Dr. Steven J. Mento Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Histogen Inc. (HSTO) Executive Chairman, Interim Pres & Chief Executive Officer 385,669 $0 $0

What does Histogen Inc. do?

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.

Steven J. Mento Ph.D. insider trading

Histogen Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 65,000 N/A N/A
Option
Common Stock 65,000 N/A N/A
Option
Common Stock 60,000 N/A N/A
Option
Stock Option (Right to Buy) 60,000 N/A N/A
Option
Common Stock 41,414 N/A N/A
Option
Stock Option (Right to Buy) 41,414 N/A N/A
Option
Stock Option (Right to Buy) 41,414 $1.12 $46,177
Option
Common Stock 41,414 $1.12 $46,177
Purchase
Common Stock 13,800 N/A N/A

Histogen key executives

Histogen Inc. executives and other stock owners filed with the SEC: